Lead Discovery Center GmbH - Product Pipeline Review - 2016

  • ID: 3821711
  • Company Profile
  • 76 pages
  • Global Markets Direct
1 of 4
Lead Discovery Center GmbH - Product Pipeline Review - 2016

Summary

‘Lead Discovery Center GmbH - Product Pipeline Review, 2016’, provides an overview of the Lead Discovery Center GmbH’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Lead Discovery Center GmbH, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Lead Discovery Center GmbH
- The report provides overview of Lead Discovery Center GmbH including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Lead Discovery Center GmbH’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Lead Discovery Center GmbH’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Lead Discovery Center GmbH’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Lead Discovery Center GmbH
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Lead Discovery Center GmbH’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Figures

Lead Discovery Center GmbH Snapshot

Lead Discovery Center GmbH Overview

Key Information

Key Facts

Lead Discovery Center GmbH - Research and Development Overview

Key Therapeutic Areas

Lead Discovery Center GmbH - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Lead Discovery Center GmbH - Pipeline Products Glance

Lead Discovery Center GmbH - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Lead Discovery Center GmbH - Drug Profiles

Small Molecule for Target RhoGEF12 for Cardiovascular Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Activate Beclin1 for Neurodegenerative Diseases and Viral Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit FKBP51 for Anxiety and Major Depressive Disorder

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Antagonize RON Kinase for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit Cyclophilin for Immunology and Respiratory Disorders

Product Description

Mechanism of Action

R&D Progress

englerin A

Product Description

Mechanism of Action

R&D Progress

Small Molecule 1 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule 2 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule 3 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule 4 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule for AMD, Inflammation and Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Amyotrophic Lateral Sclerosis

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Chlamydia Infections

Product Description

Mechanism of Action

R&D Progress

Small molecule for Multiple Sclerosis

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Activate TRIM32 for Neurodegenerative Diseases

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Agonize P2Y6R for Type 2 Diabetes

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Block TRPC4 and TRPC5 for Cardiovascular Disease and Epilepsy

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit AML1/ETO for Acute Myeloid Leukemia

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit CDK12 and CDK13 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Chemerin for Inflammation

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit degS Serine Endoprotease for Bacterial Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit GLUT1 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit GRK5 for Type 2 Diabetes

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit MARK2 for Alzheimer's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Plexin-B1/Sema4D for Multiple Sclerosis and Osteoporosis

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit RabGGTase for Solid Tumors

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit SFRP1 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Steroid Sulfatase for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Target Draxin for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Target Hedgehog Pathway for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Target K-Ras/PDE Delta for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Target Nrg1-ErbB4 Pathway for Schizophrenia and Cardiovascular Diseases

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Target SLC6A15 for Major Depressive Disorder

Product Description

Mechanism of Action

R&D Progress

Small Molecules 1 for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Charcot-Marie-Tooth Disease Type I A

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Influenza

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Lung Cancer

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Activate GFAT for Alzheimer’s Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Agonize GPR81 for Atherosclerosis and Obesity

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit LRRK2 for Parkinson's Disease

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit NET Formation for Sepsis and SLE

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Target Notch Signaling Pathway for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Target SIRT7 for Cardiovacular Diseases, Metabolic Syndrome and Oncology

Product Description

Mechanism of Action

R&D Progress

Lead Discovery Center GmbH - Pipeline Analysis

Lead Discovery Center GmbH - Pipeline Products by Target

Lead Discovery Center GmbH - Pipeline Products by Molecule Type

Lead Discovery Center GmbH - Pipeline Products by Mechanism of Action

Lead Discovery Center GmbH - Recent Pipeline Updates

Lead Discovery Center GmbH - Dormant Projects

Lead Discovery Center GmbH - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Lead Discovery Center GmbH, Key Information

Lead Discovery Center GmbH, Key Facts

Lead Discovery Center GmbH - Pipeline by Indication, 2016

Lead Discovery Center GmbH - Pipeline by Stage of Development, 2016

Lead Discovery Center GmbH - Monotherapy Products in Pipeline, 2016

Lead Discovery Center GmbH - Partnered Products in Pipeline, 2016

Lead Discovery Center GmbH - Partnered Products/ Combination Treatment Modalities, 2016

Lead Discovery Center GmbH - Out-Licensed Products in Pipeline, 2016

Lead Discovery Center GmbH - Out-Licensed Products/ Combination Treatment Modalities, 2016

Lead Discovery Center GmbH - Preclinical, 2016

Lead Discovery Center GmbH - Discovery, 2016

Lead Discovery Center GmbH - Pipeline by Target, 2016

Lead Discovery Center GmbH - Pipeline by Molecule Type, 2016

Lead Discovery Center GmbH - Pipeline Products by Mechanism of Action, 2016

Lead Discovery Center GmbH - Recent Pipeline Updates, 2016

Lead Discovery Center GmbH - Dormant Developmental Projects,2016 73List of Figures

Lead Discovery Center GmbH - Pipeline by Top 10 Indication, 2016

Lead Discovery Center GmbH - Pipeline by Stage of Development, 2016

Lead Discovery Center GmbH - Monotherapy Products in Pipeline, 2016

Lead Discovery Center GmbH - Partnered Products in Pipeline, 2016

Lead Discovery Center GmbH - Out-Licensed Products in Pipeline, 2016

Lead Discovery Center GmbH - Pipeline by Top 10 Target, 2016

Lead Discovery Center GmbH - Pipeline by Molecule Type, 2016

Lead Discovery Center GmbH - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll